NKMax America Funding & Investors
Santa Ana, CA
NKMax America is harnessing the power of the body's immune system through the development of unique Natural Killer (NK) cell therapies. NK cell adoptive immunotherapy enhances a patient's ability to destroy abnormal cells. The mission of NKMax is to improve patients'β lives in a safe and natural way through innovative cell therapy products and to ultimately become the global leader in immune cell therapeutics. More information can be found on our website www.nkmaxamerica.com
nkmaxamerica.comTotal Amount Raised: $16,000,000
NKMax America Funding Rounds
Post Ipo Debt
$5,000,000
IPO
Unknown
Seed
$11,000,000
Seed Investors
Gaingels
Funding info provided by Diffbot.